课题基金 / 基金详情

PROJECT IV - MAST CELL/MAST CELL MEDIATORS IN ISCHEMIA REPERFUSION INJURY

PROJECT IV - MAST CELL/MAST CELL MEDIATORS IN ISCHEMIA REPERFUSION INJURY
项目 IV - 肥大细胞/肥大细胞介质在缺血再灌注损伤中的作用
批准号:
6674472
负责人:
KARL FRANK AUSTEN
金额:
$17.38万
依托单位国家:
美国
项目类别:
财政年份:
2003
资助国家:
美国
项目状态:
已结题
起止时间:
2003-04-01 至 2008-03-31

项目摘要

项目成果

KARL FRANK AUSTEN的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
An episode of ischemia followed by reperfusion such as occurs in traumatic injury, certain surgical procedures and various pathological conditions, results in injury in the local tissue and remote injury in the lungs as well. Three components of the innate immune system have been implicated in the injury, natural IgM, the complement system and mast cells (MC). These studies will initially focus on defining the role of the MC and its mediators in injury (both local and remote) following ischemia in the skeletal muscle and contrast that with the injury that occurs following ischemia in the intestine. The definition of the role of the MC and its mediators will be accomplished using animals lacking critical mediators due to targeted disruptions of the genes coding for 2 different secretory granule proteases, an enzyme critical for the production of heparin, the terminal enzymes in the pathway to synthesize prostaglandin D2 and leukotriene C4 and the cytokine tumor necrosis factor alpha. Confirmation of the role of the MC and the different mediators will be accomplished by engraftment of MC-deficient mice with the normal or mutant MC. The project will next define the interaction of the MC with the other innate immune system components in order to define the interaction, if any between these different pathways. These studies will make use of the knowledge and resources provided by the other parts of this program to define the aspects of interdependence and independence among the three components in producing the local and remote injury following ischemia in these two different tissues. Mice lacking various complement component and the natural antibody will provide the opportunity to define the interactions between these different pathways. Lastly, using the knowledge gained in these studies, the mechanism of protective of preconditioning will be explored in order to distinguish whether this short period of sichemia is protective due to desensitization, exhaustion of a critical mediator(s) or via some other mechanism. From these studies, a better understanding of the role of and interaction between the different innate immune system components will be achieved which will allow better interventions to prevent these injuries.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
MAST CELL/MAST CELL MEDIATORSIN INJURY
  • 批准号:
    7428732
  • 项目类别:
  • 资助金额:
    $45.89万
  • 财政年份:
    2008
  • 负责人:
    KARL FRANK AUSTEN
  • 依托单位:
CELLULAR BIOLOGY OF MURINE MAST CELL DEVELOPMENT
  • 批准号:
    6654610
  • 项目类别:
  • 资助金额:
    $3.04万
  • 财政年份:
    2002
  • 负责人:
    KARL FRANK AUSTEN
  • 依托单位:
CELLULAR BIOLOGY OF MURINE MAST CELL DEVELOPMENT
  • 批准号:
    6496748
  • 项目类别:
  • 资助金额:
    $3.04万
  • 财政年份:
    2001
  • 负责人:
    KARL FRANK AUSTEN
  • 依托单位:
Functional Characterization of the Mouse LTC4 Synthase Gene
  • 批准号:
    6344612
  • 项目类别:
  • 资助金额:
    $20.28万
  • 财政年份:
    2000
  • 负责人:
    KARL FRANK AUSTEN
  • 依托单位:
国内基金
海外基金
Complement C6蛋白抑制DNA损伤修复增敏甲状腺乳头状癌放射性碘治疗的作用及其机制
  • 批准号:
    --
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    30万元
  • 批准年份:
    2022
  • 负责人:
    刘宇佳
  • 依托单位: